children cancer Junior.mpg

Reality of Childhood Cancer

the Story of Childhood Cancer

CASA VALENTINA EN CULIACAN SINALOA (NIÑOS CON CANCER )

Niños con cancer

Fundación José Carreras: spot tv niños con cancer (leucemia)

In The Arms of The Angel (City of Angels music video)

Hi, I'm Charlotte, most people call me Charly!I'm 7 years old and have been fighting high risk stage 3 (reclassified stage M) Neuroblastoma since December '09. I'm


a little busy at the moment, just kicking cancers butt and all that but

you can check the journal regularly to keep up with my jouney! If you

pass by, don't... forget to leave me a note in the guestbook to say "hi"!!

HI MY NAME IS DELILA WHITTENTON I HAVE PILOMYXOID ASTROCYTOMA GRADE 2, W/A CYST AND HYDROCEPHALUS, I WAS Dx JUNE 18,2008! TREATMENT WAS 48WEEKS FINISHED JULY 20 2009,ON JULY 14, 2010 I WAS Dx WITH THREE MORE TUMORS I WILL START TREATMENT AGAIN AUG.1,2010!


IF U WANT TO HELP YOU CAN DONATE .

THANK YOU FOR YOUR SUPPORT! GOD... BLESS YOU! IF YOU WOULD SIGN MY GUESSBOOK WITH YOUR THOUGHTS!

12 Young Cancer Angels

Hello, my name is Jenny, I am the mother of Junior, my son is suffering from cancer now is in the hospital for a chemotherapy cycle, is a child with a big heart, is a special person is my angel and my life, through research now my son can have an almost normal life ...



HELP Cancer Research

Important Steps in the History of Childhood Cancer Research







Multi-institution Cooperation in Clinical Trials


One of the most important contributions to developing better treatments for children with cancer was the formation by the National Cancer Institute of the first group of hospitals that agreed to cooperate in clinical trials of new drugs that had been developed to treat acute leukemia, the most common cancer among children.






Cooperative clinical trials of chemotherapy for acute leukemia were begun at seven hospitals scattered through the U.S. in 1955. Research grant support was provided by the NCI.






Leukemia Chemotherapy


The original seven member hospitals of the group were convened by the National Cancer Institute to cooperate in conducting trials of new chemotherapy for acute leukemia. This was the optimal way to quickly evaluate new chemotherapies that showed promise in laboratory experiments on leukemia cells. The first cancer clinical trials cooperative group treated only one type of childhood cancer; acute leukemia, using only one modality of treatment: chemotherapy. The era of chemotherapy for cancer had been heralded by discovery of several chemical agents that could eliminate leukemia cells from the bone marrow and circulating blood in children with acute leukemia. This was a breakthrough that demanded rapid trials of many potentially effective new agents. The NCI developed groups of institutions to cooperate in joint conduct of clinical trials to perfect new chemotherapies being developed in many laboratories. National cooperation in clinical research was very successful. Many new agents were found to be effective in treating acute leukemia and gradually the remissions of leukemia extended from several months to several years. At that time, however, there was little discussion of cures.






Treatment of Solid Tumors in Children


Due to the success of chemotherapy in acute leukemia, it was imperative to try chemotherapy against the cancers of solid organs. The NCI supported childhood cooperative research group pediatric surgeons, pediatric radiation oncologists and pediatric pathologists to their membership, in order to combine surgery, chemotherapy and radiation therapy in treating the solid malignant tumors of children. After a few years, the group required multi-disciplinary teams to be formed at each member institution. The group which had been formed originally to test chemotherapy for leukemia, was significantly re-organized to include the principal medical disciplines needed to diagnose and treat solid tumors of children as well as leukemia.






Multi-Disciplinary Team Care of Childhood Cancer


Childhood cancer groups developed special national studies combining surgery, chemotherapy and radiation therapy to treat certain types of cancers of the kidneys and muscles which occurred mainly in children. Combined modalities of treatment, including surgery, chemotherapy and radiation therapy were found to produce the best results for these childhood solid tumors after surgical removal of as much of the tumor as possible.






New treatments based on immunology, bone marrow and stem cell transplantation and newer treatments derived from molecular biology and genetics are now in increasingly wider use as the research horizon expands. Multi-institution clinical trials by cancer clinical researchers are the most efficient way to apply new laboratory discoveries to advance diagnosis, selection of the most appropriate treatment and, increasingly, to prevent cancer.






The best response and survival rates of children with cancer have been achieved by treatment according to a clinical trial protocol at a cooperative group member hospital with experience in conducting multi-disciplinary clinical trials. To participate in cooperative national clinical trials, a member institution now must have a multi-disciplinary team of experts that can comply with all diagnosis, treatment, supportive care and laboratory requirements of cooperative clinical trial protocols and provide combinations of treatments adjusted to the needs of each child.






Laboratory and Translational Research on Childhood Cancer


Research in cellular and molecular biology, genetics, immunology and epidemiology has become an important aspect of cooperative group cancer research. To improve diagnostic evaluation, to develop new treatments and to evaluate how they affect cancer cells, many group member institutions developed laboratory research programs to further accelerate progress in diagnosis, treatment and cure of all types of cancers that attack children. The cooperative groups have incorporated laboratory research programs in many basic sciences. These have led to new understandings of how normal cells transform into cancer cells and how to develop therapies to overcome that process without harm to normal cells and tissues. Current treatments that directly affect only cancer cells are referred to as “targeted” therapy. Many of the important discoveries of the Human Genome Project have led to better diagnosis and treatments.






The majority of the laboratory researchers conducting research related to childhood cancer are located at academic medical centers throughout the U.S. and Canada. When they produce laboratory research findings which have potential application to diagnosis, treatment, supportive care or prevention of childhood cancer, they have ready access to their clinical colleagues on the COG team at their institution. One of the primary objectives of the COG is to facilitate the translation of important laboratory research to clinical applications to benefit children with cancer. This has been a research priority of COG institutions for several decades.






The Concept of Total Cure


A major emphasis for the past two dozen years has been on improving the quality of life for patients cured of cancer during childhood. The modern definition of “cure” for children goes far beyond achieving disappearance of the evidences of cancer. It now includes the goals of psychosocial, educational, and occupational reintegration of the child into a successful life. In social terms, the impact of this achievement is considerable: The cure of a child saves an entire lifetime.


Support Research


Help CureSearch Reach the Day

Beautiful Face of Cancer

Beautiful Face of Cancer

Childhood Cancer Neuroblastoma

the Story of Childhood Cancer

stop childhood cancer promo